|
Sign In to gain access to subscriptions and/or personal tools.
|
Neurofibromatosis Type 1: Magnetic Resonance Imaging Findings
Francis J. DiMario, Jr, MD
Neurogenetics Clinic and the Department of Pediatrics-Divisions of Pediatric Neurology, The University of Connecticut Health Center, Farmington, CT
Gale Ramsby, MD, FACA
Department of Radiology, The University of Connecticut Health Center, Farmington, CT
Robert Greenstein, MD
Division of Human Genetics, The University of Connecticut Health Center, Farmington, CT
Sharon Langshur, MS
Division of Human Genetics, The University of Connecticut Health Center, Farmington, CT
Barbara Dunham, RN
Neurogenetics Clinic and the Department of Pediatrics-Divisions of Pediatric Neurology, The University of Connecticut Health Center, Farmington, CT
The purpose of this study was to determine the locations and characterize the types of brain abnormalities noted on brain magnetic resonance imaging in patients with probable and definite neurofibromatosis type 1. Patients with definite neurofibromatosis type 1 (n = 17) were studied when clinically indicated, and patients with probable neurofibromatosis type 1 (n = 9) were studied to evaluate for asymptomatic optic pathway glioma. Of the 26 patients evaluated, 14 (53%) had high-intensity signal abnormalities and 11 (42%) had significant structural abnormalities. Subsequent clinical follow-up has confirmed conversion to a definite neurofibromatosis type 1 diagnosis in three of the four cases of probable neurofibromatosis type 1 who had high-intensity signal abnormalities. The most common locations of high-intensity signal lesions were in the globus pallidus of the basal ganglia and cerebellar white matter. Tortuous or thickened optic nerves and/or optic chiasm were seen in eight cases. Brain magnetic resonance imaging scans frequently reveal high-intensity signal lesions and structural abnormalities in selected patients with both probable and definite neurofibromatosis type 1. These findings may allow for a definitive diagnosis in clinically probable cases. (J Child Neurol 1993;8:32-39).
Journal of Child Neurology, Vol. 8, No. 1,
32-39 (1993)
DOI: 10.1177/088307389300800105

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. C. M. Chang, G. Mirabella, R. Yagev, M. Banh, E. Mezer, P. C. Parkin, C. A. Westall, and J. R. Buncic
Screening and Diagnosis of Optic Pathway Gliomas in Children with Neurofibromatosis Type 1 by Using Sweep Visual Evoked Potentials
Invest. Ophthalmol. Vis. Sci.,
June 1, 2007;
48(6):
2895 - 2902.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G.T. Armstrong, A.R. Localio, T. Feygin, L. Bilaniuk, P.C. Phillips, M.J. Fisher, B.L. Strom, and R. Zimmerman
Defining Optic Nerve Tortuosity
AJNR Am. J. Neuroradiol.,
April 1, 2007;
28(4):
666 - 671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.L. Hyman, D.S. Gill, E.A. Shores, A. Steinberg, P. Joy, S.V. Gibikote, and K.N. North
Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1
Neurology,
April 8, 2003;
60(7):
1139 - 1145.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.M. Friedman
Review Article : Neurofibromatosis 1: Clinical Manifestations and Diagnostic Criteria
J Child Neurol,
August 1, 2002;
17(8):
548 - 554.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. F. Parsa, C. S. Hoyt, R. L. Lesser, J. M. Weinstein, C. M. Strother, R. Muci-Mendoza, M. Ramella, R. S. Manor, W. A. Fletcher, M. X. Repka, et al.
Spontaneous Regression of Optic Gliomas: Thirteen Cases Documented by Serial Neuroimaging
Arch Ophthalmol,
April 1, 2001;
119(4):
516 - 529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J-F Chateil, C Soussotte, J-M Pedespan, M Brun, C Le Manh, and F Diard
MRI and clinical differences between optic pathway tumours in children with and without neurofibromatosis
Br. J. Radiol.,
January 1, 2001;
74(877):
24 - 31.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. DiMario JR and S. Langshur
Headaches in Patients With Neurofibromatosis-1
J Child Neurol,
April 1, 2000;
15(4):
235 - 238.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. DeBella, J. Szudek, and J. M. Friedman
Use of the National Institutes of Health Criteria for Diagnosis of Neurofibromatosis 1 in Children
Pediatrics,
March 1, 2000;
105(3):
608 - 614.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
F. J. DiMario Jr, G. R. Ramsby, and J. A. Burleson
Brain Morphometric Analysis in Neurofibromatosis 1
Arch Neurol,
November 1, 1999;
56(11):
1343 - 1346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. D. Griffiths, F. PhD, S. Blaser, W. Mukonoweshuro, D. Armstrong, G. Milo-Manson, and S. Cheung
Neurofibromatosis Bright Objects in Children With Neurofibromatosis Type 1: A Proliferative Potential?
Pediatrics,
October 1, 1999;
104(4):
49e - 49.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Creange, J. Zeller, S. Rostaing-Rigattieri, P. Brugieres, J.-D. Degos, J. Revuz, and P. Wolkenstein
Neurological complications of neurofibromatosis type 1 in adulthood
Brain,
March 1, 1999;
122(3):
473 - 481.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. DiMario Jr and G. Ramsby
Magnetic Resonance Imaging Lesion Analysis in Neurofibromatosis Type 1
Arch Neurol,
April 1, 1998;
55(4):
500 - 505.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|